Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Abstract 5370: CARG-2020 a novel immunemodulatory approach to prevent recurrent ovarian cancer

Ayesha B. Alvero, Alexandra Fox, Bhaskara Madina, Marie Krady, Timur O. Yarovinski, Valerian Nakaar, Bijan Almassian, Gil Mor

Cancer Res (2022) 82 (12_Supplement): 5370.

https://doi.org/10.1158/1538-7445.AM2022-5370

Published: 15 June 2022

View article titled, Abstract 5370: CARG-2020 a novel immunemodulatory approach to prevent recurrent ovarian cancer

Journal Articles

Abstract 2333: EMT programs ovarian cancer cells to survive the adipocyte-rich microenvironment

Hussein Chehade, Alexandra Fox, Roslyn Tedja, Radhika Gogoi, Gil Mor, Ayesha B. Alvero

Cancer Res (2021) 81 (13_Supplement): 2333.

https://doi.org/10.1158/1538-7445.AM2021-2333

Published: 01 July 2021

View article titled, Abstract 2333: EMT programs ovarian cancer cells to survive the adipocyte-rich microenvironment

Journal Articles

Abstract 1150: CARG-2020 artificial oncolytic virus delivering three immune-modulators prevents tumor recurrence in a syngeneic model of ovarian cancer

Ayesha B. Alvero, Alexandra Fox, Bhaskara Madina, Valerian Nakaar, Timur Yarovinsky, Marie Krady, Bijan Almassian, Gil Mor

Cancer Res (2021) 81 (13_Supplement): 1150.

https://doi.org/10.1158/1538-7445.AM2021-1150

Published: 01 July 2021

View article titled, Abstract 1150: CARG-2020 artificial oncolytic virus delivering three immune-modulators prevents tumor recurrence in a syngeneic model of ovarian cancer

Journal Articles

Abstract 3188: Transimmunization prevents recurrence and reprograms the immune milieu in a mouse model of ovarian cancer

Ayesha B. Alvero, Douglas Hanlon, Mary Pitruzzello, Renata Filler, Eve Robinson, Olga Sobolev, Roslyn Tedja, Alessandra Ventura, Richard L. Edelson, Gil Mor

Cancer Res (2019) 79 (13_Supplement): 3188.

https://doi.org/10.1158/1538-7445.AM2019-3188

Published: 01 July 2019

View article titled, Abstract 3188: Transimmunization prevents recurrence and reprograms the immune milieu in a mouse model of ovarian cancer

Journal Articles

Abstract LB-352: p53-promoted Twist1 degradation inhibits EMT in ovarian cancer cells

Yang Yang-Hartwich, Roslyn Tedja, Jamie Bingham, Marta Gurrea Soteras, Ayesha B. Alvero, Gil Mor

Cancer Res (2016) 76 (14_Supplement): LB-352.

https://doi.org/10.1158/1538-7445.AM2016-LB-352

Published: 15 July 2016

View article titled, Abstract LB-352: p53-promoted Twist1 degradation inhibits EMT in ovarian cancer cells

Journal Articles

Abstract LB-201: Preclinical toxicology of TRXE-002-1

Kimberley Lilischkis, Andrew Heaton, Ayesha Alvero, Gil Mor, David M. Brown

Cancer Res (2016) 76 (14_Supplement): LB-201.

https://doi.org/10.1158/1538-7445.AM2016-LB-201

Published: 15 July 2016

View article titled, Abstract LB-201: Preclinical toxicology of TRXE-002-1

Journal Articles

Abstract 4201: Targeting tumor-associated neovasculature for delivery of optical enhancers detects ovarian cancer micrometastasis

Ayesha B. Alvero, Eydis Lima, Dongin Kim, Sean Orton, Natalia Sumi, Mary Pitruzzello, Yang Yang-Hartwich, Dan-Arin Silasi, Tarek Fahmy, Gil Mor

Cancer Res (2016) 76 (14_Supplement): 4201.

https://doi.org/10.1158/1538-7445.AM2016-4201

Published: 15 July 2016

View article titled, Abstract 4201: Targeting tumor-associated neovasculature for delivery of optical enhancers detects ovarian cancer micrometastasis

Journal Articles

Abstract 12: Bclxl is a key regulator of mitochondria-induced apoptosis in ovarian cancer stem cells

Ayesha B. Alvero, Mary Pitruzello, Michele Montagna, Eydis Lima, Gil Mor

Cancer Res (2015) 75 (15_Supplement): 12.

https://doi.org/10.1158/1538-7445.AM2015-12

Published: 01 August 2015

View article titled, Abstract 12: Bclxl is a key regulator of mitochondria-induced apoptosis in ovarian cancer stem cells

Journal Articles

Abstract LB-014: Targeting p53 aggregation in ovarian cancer chemoresistant cells

Yang Yang-Hartwich, Carlos Cardenas, Mary Pitruzzello, Eydis Lima, Ayesha B. Alvero, Gil Mor

Cancer Res (2015) 75 (15_Supplement): LB-014.

https://doi.org/10.1158/1538-7445.AM2015-LB-014

Published: 01 August 2015

View article titled, Abstract LB-014: Targeting p53 aggregation in ovarian cancer chemoresistant cells

Journal Articles

Abstract B75: TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian Cancer Cells through MIR199A2/214

Gang Yin, Rui Chen, Han‐Hsuan Fu, Ayesha Alvero, Carlotta Glackin, Gil Mor

Cancer Res (2009) 69 (23_Supplement): B75.

https://doi.org/10.1158/0008-5472.FBCR09-B75

Published: 28 October 2014

View article titled, Abstract B75: TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian Cancer Cells through MIR199A2/214

Journal Articles

Abstract 1974: Ovulatory wound: the site of origin for ovarian serous carcinoma

Yang Yang-Hartwich, Marta Gurrea, Natalia Sumi, Jennie Holmberg, Vinicius Craveiro, Ayesha Alvero, Gil Mor

Cancer Res (2014) 74 (19_Supplement): 1974.

https://doi.org/10.1158/1538-7445.AM2014-1974

Published: 01 October 2014

View article titled, Abstract 1974: Ovulatory wound: the site of origin for ovarian serous carcinoma

Journal Articles

Abstract 4319: Inability of putative ovarian cancer stem cells to engage OXPHOS confer 2-deoxyglucose-mediated prevention of in vivo recurrence

Ayesha B. Alvero, Michele Montagna, Natalia J. Sumi, Won Duk Joo, Vinicius Craveiro, Emma Graham, Gil Mor

Cancer Res (2014) 74 (19_Supplement): 4319.

https://doi.org/10.1158/1538-7445.AM2014-4319

Published: 01 October 2014

View article titled, Abstract 4319: Inability of putative ovarian cancer stem cells to engage OXPHOS confer 2-deoxyglucose-mediated prevention of <em>in vivo</em> recurrence

Journal Articles

Abstract LB-286: ME-344 delays tumor kinetics in an ovarian cancer in vivo recurrence model.

Ayesha B. Alvero, Natalia Sumi, Vinicius Craveiro, Won Duk Joo, Yang Yang-Hartwich, Gil Mor

Cancer Res (2013) 73 (8_Supplement): LB-286.

https://doi.org/10.1158/1538-7445.AM2013-LB-286

Published: 15 April 2013

View article titled, Abstract LB-286: ME-344 delays tumor kinetics in an ovarian cancer <em>in vivo</em> recurrence model.

Journal Articles

Abstract 3471: Paclitaxel selects and enriches for CD44+/MyD88+ ovarian cancer stem cells

Ayesha B. Alvero, Vinicius Craveiro, Jennie Holmberg, Yang Yang, Gil Mor

Cancer Res (2012) 72 (8_Supplement): 3471.

https://doi.org/10.1158/1538-7445.AM2012-3471

Published: 15 April 2012

View article titled, Abstract 3471: Paclitaxel selects and enriches for CD44+/MyD88+ ovarian cancer stem cells

Journal Articles

Abstract 5259: Non-invasive determination of in vivo myeloperoxidase activity in ovarian cancer mouse model

Rao V. Papineni, Vinicius Craveiro, John Pizzonia, Jennie Holmberg, Gil Mor

Cancer Res (2012) 72 (8_Supplement): 5259.

https://doi.org/10.1158/1538-7445.AM2012-5259

Published: 15 April 2012

View article titled, Abstract 5259: Non-invasive determination of in vivo myeloperoxidase activity in ovarian cancer mouse model

Journal Articles

Abstract 3405: Epithelial ovarian cancer stem cells are the source of metastatic progenitor cells

Gang Yin, Vinny Craveiro, Jennie Holmberg, Han-Hsuan Fu, Michael K. Montagna, Ayesha Alvero, Gil Mor

Cancer Res (2011) 71 (8_Supplement): 3405.

https://doi.org/10.1158/1538-7445.AM2011-3405

Published: 15 April 2011

View article titled, Abstract 3405: Epithelial ovarian cancer stem cells are the source of metastatic progenitor cells

Journal Articles

Abstract LB-221: Depression of mitochondrial bioenergetics is a potent death stimulus in the ovarian cancer stem cells

Ayesha B. Alvero, Michele K. Montagna, Jennie C. Holmberg, David Brown, Gil Mor

Cancer Res (2011) 71 (8_Supplement): LB-221.

https://doi.org/10.1158/1538-7445.AM2011-LB-221

Published: 15 April 2011

View article titled, Abstract LB-221: Depression of mitochondrial bioenergetics is a potent death stimulus in the ovarian cancer stem cells

Journal Articles

Abstract 131: Mechanisms by which 2,3’, 4,5’ tetramethoxystilbene (TMS), a resveratrol derivative, induces death in breast cancer cells

Sarah E. Aiyar, Richard J. Santen, Hoyong Park, Paula B. Aldo, Gil Mor

Cancer Res (2010) 70 (8_Supplement): 131.

https://doi.org/10.1158/1538-7445.AM10-131

Published: 15 April 2010

View article titled, Abstract 131: Mechanisms by which 2,3’, 4,5’ tetramethoxystilbene (TMS), a resveratrol derivative, induces death in breast cancer cells

Journal Articles

Abstract 4229: Wound repair promotes ovarian cancer stem cell self-renewal

Ilana Chefetz-Menaker, Noah Lebowitz, Paolomi Aldo, Ayesha Alvero, Jennie Holmberg, Gil Mor

Cancer Res (2010) 70 (8_Supplement): 4229.

https://doi.org/10.1158/1538-7445.AM10-4229

Published: 15 April 2010

View article titled, Abstract 4229: Wound repair promotes ovarian cancer stem cell self-renewal

Journal Articles

Abstract 3342: Specific inhibition of IKKβ induces caspase-independent cell death in the ovarian cancer stem cells

Ayesha B. Alvero, Michele K. Montagna, Jennie Holmberg, Gil Mor

Cancer Res (2010) 70 (8_Supplement): 3342.

https://doi.org/10.1158/1538-7445.AM10-3342

Published: 15 April 2010

View article titled, Abstract 3342: Specific inhibition of IKKβ induces caspase-independent cell death in the ovarian cancer stem cells

NARROW

Abstract 5370: CARG-2020 a novel immunemodulatory approach to prevent recurrent ovarian cancer

Abstract 2333: EMT programs ovarian cancer cells to survive the adipocyte-rich microenvironment

Abstract 1150: CARG-2020 artificial oncolytic virus delivering three immune-modulators prevents tumor recurrence in a syngeneic model of ovarian cancer

Abstract 3188: Transimmunization prevents recurrence and reprograms the immune milieu in a mouse model of ovarian cancer

Abstract LB-352: p53-promoted Twist1 degradation inhibits EMT in ovarian cancer cells

Abstract LB-201: Preclinical toxicology of TRXE-002-1

Abstract 4201: Targeting tumor-associated neovasculature for delivery of optical enhancers detects ovarian cancer micrometastasis

Abstract 12: Bclxl is a key regulator of mitochondria-induced apoptosis in ovarian cancer stem cells

Abstract LB-014: Targeting p53 aggregation in ovarian cancer chemoresistant cells

Abstract B75: TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian Cancer Cells through MIR199A2/214

Abstract 1974: Ovulatory wound: the site of origin for ovarian serous carcinoma

Abstract 4319: Inability of putative ovarian cancer stem cells to engage OXPHOS confer 2-deoxyglucose-mediated prevention of in vivo recurrence

Abstract LB-286: ME-344 delays tumor kinetics in an ovarian cancer in vivo recurrence model.

Abstract 3471: Paclitaxel selects and enriches for CD44+/MyD88+ ovarian cancer stem cells

Abstract 5259: Non-invasive determination of in vivo myeloperoxidase activity in ovarian cancer mouse model

Abstract 3405: Epithelial ovarian cancer stem cells are the source of metastatic progenitor cells

Abstract LB-221: Depression of mitochondrial bioenergetics is a potent death stimulus in the ovarian cancer stem cells

Abstract 131: Mechanisms by which 2,3’, 4,5’ tetramethoxystilbene (TMS), a resveratrol derivative, induces death in breast cancer cells

Abstract 4229: Wound repair promotes ovarian cancer stem cell self-renewal

Abstract 3342: Specific inhibition of IKKβ induces caspase-independent cell death in the ovarian cancer stem cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only